Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Blood test highly accurate at spotting early brain changes of Alzheimer’s

Staff Writer
Staff Writer 3 years ago
Updated 2019/08/06 at 12:00 AM
Share
SHARE

Based on new findings by researchers at Washington University School of Medicine, a blood test capable of identifying brain changes of Alzheimer’s disease with high accuracy before symptoms emerge might soon be put to clinical use.

According to the study, released in the journal Neurology, researchers were able to measure blood levels of amyloid-beta, a protein associated with the neurodegenerative disease, with a 94 percent accuracy to predict whether the protein had build-up in the brain. The study may lead researchers to faster screening in patients, potentially more efficient than the conventional method by PET scans. The findings could also aid in the development of new treatments through clinical trials.

“Right now we screen people for clinical trials with brain scans, which is time-consuming and expensive, and enrolling participants takes years,” said Dr. Randall Bateman, senior author of the study. “But with a blood test, we could potentially screen thousands of people a month. That means we can more efficiently enroll participants in clinical trials, which will help us find treatments faster, and could have an enormous impact on the cost of the disease as well as the human suffering that goes with it.”

Using mass spectrometry, a technique tested in previous studies, researchers measured the quantity of two forms of amyloid-beta in the blood: amyloid-beta 42 and amyloid-beta 40, in 158 adult participants over the age of 50. 10 of the participants were classified as cognitively healthy. All the participants underwent at least one blood test and PET scan, with each blood sample and PET scan receiving a classification of either amyloid positive or negative.

Upon examination, each participant’s blood test was in accordance with their PET scan 88 percent of the time. However, to strengthen the test’s accuracy, researchers took things a step further and included major risk factors associated with Alzheimer’s, such as age and a genetic variant known as APOE4. The inclusion of these two risk factors improved the accuracy of the blood test by 94 percent, the findings showed.

In another part of the study, researchers reaffirmed the significance of blood tests in improving prescreening of Alzheimer’s. The team probed an Alzheimer’s prevention trial called the A4 study, which utilized PET scans to identify early brain changes among participants. This study concluded blood testing after PET scanning could have decreased the number of PET scans by two thirds and saved a drastic amount of monetary loss.

“Reducing the number of PET scans could enable us to conduct twice as many clinical trials for the same amount of time and money. It’s not the $4,000 per PET scan that we’re worried about. It’s the millions of patients that are suffering while we don’t have a treatment. If we can run these trials faster, that will get us closer to ending this disease,” Bateman stated.

You Might Also Like

Study finds mental distress affects almost half of all teenage females in Norway

ICD-11 lists complex post-traumatic stress disorder as a new condition

New research identifies personality traits linked to cognitive deficits

Many known biological pathways in the brain are impacted by Alzheimer’s disease

Immune system and CNS may play a major role in ALS

TAGGED: APOE4, Alzheimer's disease, amyloid beta, cognition
Staff Writer August 6, 2019
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Voters want more science-based discussion this election, survey shows
Next Article Dietary choline intake linked to lower risk of dementia

Recommended

Clinical

Study finds mental distress affects almost half of all teenage females in Norway

1 Min Read
Clinical

ICD-11 lists complex post-traumatic stress disorder as a new condition

1 Min Read
Clinical

New research identifies personality traits linked to cognitive deficits

1 Min Read
Clinical

Many known biological pathways in the brain are impacted by Alzheimer’s disease

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?